Advertisement

Topics

Bayer Announces that Loxo Oncology, Inc., Initiates Rolling NDA Submission for Larotrectinib ...

06:46 EST 20 Dec 2017 | BioMedReports - Blog

WHIPPANY, N.J., Dec. 20, 2017/PRNewswire/ -- Bayer today announced that its collaboration partner Loxo Oncology, Inc., (NASDAQ: LOXO) has initiated the submission of

Read more...

Original Article: Bayer Announces that Loxo Oncology, Inc., Initiates Rolling NDA Submission for Larotrectinib ...

NEXT ARTICLE

More From BioPortfolio on "Bayer Announces that Loxo Oncology, Inc., Initiates Rolling NDA Submission for Larotrectinib ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...